These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20535122)

  • 1. Angiotensin II receptor blockers and insulin resistance.
    Ciccarelli L
    Hypertens Res; 2010 Aug; 33(8):779. PubMed ID: 20535122
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of angiotensin II receptor blockers on insulin resistance.
    Ragonesi PD
    Hypertens Res; 2010 Aug; 33(8):778. PubMed ID: 20555329
    [No Abstract]   [Full Text] [Related]  

  • 3. Of the renin-angiotensin system and reactive oxygen species Type 2 diabetes and angiotensin II inhibition.
    Leiter LA; Lewanczuk RZ
    Am J Hypertens; 2005 Jan; 18(1):121-8. PubMed ID: 15691626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy of angiotensin receptor blocker with statin or thiazolidinediones as promising therapeutic strategy for metabolic syndrome and atherosclerosis.
    Kim-Mitsuyama S
    Hypertens Res; 2009 Aug; 32(8):639-40. PubMed ID: 19543234
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating the metabolic syndrome using angiotensin receptor antagonists that selectively modulate peroxisome proliferator-activated receptor-gamma.
    Pershadsingh HA
    Int J Biochem Cell Biol; 2006; 38(5-6):766-81. PubMed ID: 16298156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome: treatment of hypertensive patients.
    Israili ZH; Lyoussi B; Hernández-Hernández R; Velasco M
    Am J Ther; 2007; 14(4):386-402. PubMed ID: 17667215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New treatment strategies for patients with hypertension and insulin resistance.
    Kurtz TW
    Am J Med; 2006 May; 119(5 Suppl 1):S24-30. PubMed ID: 16563944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin system and angiotensin receptor blockers in the metabolic syndrome.
    Prasad A; Quyyumi AA
    Circulation; 2004 Sep; 110(11):1507-12. PubMed ID: 15364819
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of telmisartan on fat distribution in individuals with the metabolic syndrome.
    Shimabukuro M; Tanaka H; Shimabukuro T
    J Hypertens; 2007 Apr; 25(4):841-8. PubMed ID: 17351377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [PPARgamma-activating properties of angiotensin receptor blockers].
    Ando H; Fujimura A
    Nihon Rinsho; 2006 Jul; 64 Suppl 5():498-501. PubMed ID: 16895217
    [No Abstract]   [Full Text] [Related]  

  • 11. Partial peroxisome proliferator-activated receptor agonist angiotensin receptor blockers. Potential multipronged strategy in stroke prevention.
    Towfighi A; Ovbiagele B
    Cerebrovasc Dis; 2008; 26(2):106-12. PubMed ID: 18560212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In the framework of the 72nd Annual Meeting of the DKG (German CardiologySociety) in Mannheim presented: Ontarget-the until now largest study program on cardiovascular prevention in patients with hypertension].
    MMW Fortschr Med; 2006 Jun; 148(26):50-1. PubMed ID: 16875381
    [No Abstract]   [Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors or angiotensin receptor blockers for prevention of type 2 diabetes: a meta-analysis of randomized clinical trials.
    Abuissa H; Jones PG; Marso SP; O'Keefe JH
    J Am Coll Cardiol; 2005 Sep; 46(5):821-6. PubMed ID: 16139131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evidences of ARB interventional studies that prevent the progression of hypertension and hypertensive target organ damage].
    Shigematsu Y; Higaki J
    Nihon Rinsho; 2011 Jan; 69 Suppl 1():597-600. PubMed ID: 21766667
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of telmisartan and amlodipine on metabolic parameters and blood pressure in type 2 diabetic, hypertensive patients.
    Negro R; Hassan H
    J Renin Angiotensin Aldosterone Syst; 2006 Dec; 7(4):243-6. PubMed ID: 17318795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy of hypertension in patients with type 2 diabetes mellitus].
    Hess K
    Dtsch Med Wochenschr; 2012 Nov; 137(48):2489-92. PubMed ID: 23114910
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of telmisartan and losartan on insulin resistance in hypertensive patients with metabolic syndrome.
    Bahadir O; Uzunlulu M; Oguz A; Bahadir MA
    Hypertens Res; 2007 Jan; 30(1):49-53. PubMed ID: 17460371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with non-insulin depending diabetes mellitus and metabolic syndrome are suboptimal treated in Swiss primary care.
    Schäfer HH; de Villiers JD; Lotze U; Sivukhina E; Burnier M; Noll G; Theus GR; Dieterle T
    Clin Exp Hypertens; 2013; 35(7):496-505. PubMed ID: 23301512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolic syndrome in hypertension: European society of hypertension position statement.
    Redon J; Cifkova R; Laurent S; Nilsson P; Narkiewicz K; Erdine S; Mancia G;
    J Hypertens; 2008 Oct; 26(10):1891-900. PubMed ID: 18806611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin resistance increases the risk of urinary stone formation in a rat model of metabolic syndrome.
    Iba A; Kohjimoto Y; Mori T; Kuramoto T; Nishizawa S; Fujii R; Nanpo Y; Matsumura N; Shintani Y; Inagaki T; Hara I
    BJU Int; 2010 Nov; 106(10):1550-4. PubMed ID: 20184575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.